Dong Qing's husband, returned after half a year "lost contact"

Recently, the news of the well -known capital of Shanghai, Mi Chunlei, "lost contact", and returned to the news after nearly half a year.

After the market on July 6, the delisting sea doctor (hereinafter referred to as "Lanhai Medical", 600896.SH) announced that the company's director and chairman Mr. Mi Chunlei licensed the company's director Ni Xiaowei for personal reasons It expired on July 6, 2022. Since July 7, 2022, Mr. Michun Lei has fulfilled his duties and chairman of the company normally, and no longer authorizes Mr. Ni Xiaowei to fulfill his duties of chairman.

In many media reports, another more well -known identity of Mi Chunlei is the husband of Dong Qing, a well -known host.

On July 7th, stimulated by this news, as of the close, the Luanhai Medical Newspaper was 1.11 yuan, up 9.90%, with a total market value of 1.1 billion.

The duties of the chairman of the chairman of others twice

Public information shows that Luanhai Medical was established in 1993 and is located in Shanghai. It is mainly engaged in the investment construction and operation management business of high -end medical projects including comprehensive hospitals, specialized hospitals, and outpatients.

On January 28 this year, Lanhai Medical Announcement recently received written authorization from the company's chairman Mr. Mi Chunlei. The meeting was reviewed and approved, and agreed to recommend the responsibilities of the chairman of the company's chairman of the company.

However, Mi Chunlei did not continue to fulfill the duties of the chairman as scheduled. More than two months later, Lanhai Medical announced on April 11 that recently received written authorization issued by the company's chairman Mr. Mi Chunlei again. From 3 months on the 7th.

The dedication of delisting is imminent

This time, after the expiration of the 3 months, Michri finally returned as scheduled. But the situation he was facing was quite embarrassing: the dedication of delisting was imminent, and the administrative regulatory measures of the regulatory level followed closely.

On June 20, Lanhai Medical stated that he received the announcement of the decision to terminate the listing of the stock. The reason for the termination of listing is that due to the negative value of the audit in 2020 and the operating income of less than RMB 100 million, the company's shares have been implemented from the implementation of the delisting risk from May 6, 2021.

In addition, the starting date of the transaction period of the company's retirement period is June 28, 2022, and the final transaction date is expected to be July 18, 2022. This also means that the delisting is only 12 days.

On the same day, Lanhai Medical also stated that he had received the announcement of the China Securities Regulatory Commission Hainan Supervision Bureau's "Decision on Administrative Supervision Measures" (hereinafter referred to as the "Decision").

The announcement said that after investigation, the company had the following violations: First, the funds occupied by related parties were not disclosed in accordance with regulations. In 2021, your company has the control of the controlling shareholders and its non -operating funds. The cumulative amount of 575,051,084 yuan is cumulative. The funds and corresponding interest occupied by related parties have been returned on June 7, 2022. Your company fails to fulfill the obligation to disclose the information disclosure of the above -mentioned related party funds in accordance with regulations, and does not meet the relevant provisions of Article 3 and 41 of the "Administrative Measures for the Information Disclosure of Listed Companies" (Order 182 of the CSRC).

The second is that the claims of the affiliated parties were not recovered in time. On November 6, 2020, your company disclosed the "Announcement on Providing Shareholders Loaning and Related Transactions to Shanghai Hefeng Hospital Co., Ltd." to Shanghai Hefeng Hospital Co., Ltd. ", saying that your company and controlling shareholder Shanghai Luanhai Investment Co., Ltd. (hereinafter referred to as Shanghai Lana Sea) Signing the "Asset Transfer Agreement" with an effective part of the attachment, stipulating that the company intends to hold a 51 % equity of Shanghai Hefeng Hospital Co., Ltd. (hereinafter referred to as Hefeng Hospital) and its original 952,474 million yuan in debt to Hefeng Hospital. RMB 517.804 million was transferred to Shanghai Lanhai. After the transfer, the company holds 44 % of the shares of Hefeng Hospital, and the balance of the claims of Hefeng Hospital is 44,069,600 yuan. In order to confirm the relevant debt, your company signed the "Loan Agreement" with Hefeng Hospital. One year after the transaction is completed, the annual interest rate of borrowing is 6%. On January 25, 2021, your company completed the asset transfer procedures for 51%of the equity of Hefeng Hospital. The above claims have expired on January 24, 2022. Your company failed to recover in time, and did not recover the announcement of the issuance of the debt in time. The information disclosure was not timely. The relevant regulations of the five articles.

According to the "Decision", Mi Chunlei is related to the above matters. The Hainan Regulatory Bureau believes that Mi Chunlei, as the chairman of the company, Liu Lei, as the then executive vice president and chief financial officer, Cai Zehua, as the chief financial officer, as the secretary of the board of directors, has its main responsibility for the above issues, violated the "information disclosure management of listed companies' information disclosure management The provisions of Article 4 of the Measures.

According to Article 51 and 52 of the "Administrative Measures for the Information Disclosure of Listed Companies", the bureau decided to take administrative supervision measures with alert letter with alert letter, Mi Chunlei, Liu Lei, Cai Zehua, and He Yongxiang. And record in the capital market integrity information database.

On the afternoon of July 7, when a reporter from the Nandu Bay Cultural Affairs called the delisting sea doctor, the relevant staff of the company stated that he did not pay attention to whether the Michimi came to the company, but he started his duties normally from today.

Now, can Michunlei turn the tide?Can Lanhai Medical "come back" and avoid the ending of the market?It is unknown.Source: Southern Metropolis Daily

- END -